ENTITY
Shinpoong Pharmaceutical

Shinpoong Pharmaceutical (019170 KS)

79
Analysis
Health Care • South Korea
Shin Poong Pharmaceutical Co., Ltd. manufactures pharmaceutical raw materials and prescription drugs, such as cephalosporin antibiotics, hemostatics, sedative agents, and anti-diabetics.
more
•04 Nov 2025 16:51•Primer

Primer: Shinpoong Pharmaceutical (019170 KS) - Nov 2025

Shinpoong Pharmaceutical is a South Korean pharmaceutical company transitioning from a generics manufacturer to an R&D-focused entity,...

Logo
αSK
409 Views
Share
bullish•KB Financial
•15 Dec 2024 06:19

A Review of Major Equity Indices in Korea in 2024

We review the major equity indices in Korea in 2024 including KOSPI 200 and Korea Value Up Index. KRX plans to make special changes to the Korea...

Logo
590 Views
Share
•10 Nov 2024 07:30

APAC Healthcare Weekly (Nov 10)- Alteogen, Santen Pharmaceutical, Beigene, Sun Pharmaceutical

​Alteogen partners with Daiichi Sankyo for Enhertu, Volpara secures $7.3M contract, Santen launches Rhopressa in South Korea, Sun Pharma's Leqselvi...

Logo
935 Views
Share
bearish•Quantitative Analysis
•30 Oct 2024 06:00

KRX Short Interest Weekly (Oct 25th): Korzinc, Hlb, LG Electronics

We analyzed KRX short interest report for the past week and highlighted short interest changes in Korzinc, Hlb, LG Electronics.

Logo
365 Views
Share
bullish•CosmoAM&T
•12 Jun 2024 05:07

KOSPI200 Index Rebalance: Index Committee Knows Best; Cosmo AM&T the Winner

The KOSPI200 rebalance takes place at the close tomorrow. Cosmo AM&T is up ~25% since the surprise inclusion and there could be a reversal in the...

Logo
811 Views
Share
x